Cite
Fibrinolysis in COVID-19: Impact on Clot Lysis and Modulation of Inflammation.
MLA
Sugimoto, Michelle A., et al. “Fibrinolysis in COVID-19: Impact on Clot Lysis and Modulation of Inflammation.” Current Drug Targets, vol. 23, no. 17, 2022, pp. 1578–92. EBSCOhost, https://doi.org/10.2174/1389450123666221011102250.
APA
Sugimoto, M. A., Perucci, L. O., Tavares, L. P., Teixeira, M. M., & Sousa, L. P. (2022). Fibrinolysis in COVID-19: Impact on Clot Lysis and Modulation of Inflammation. Current Drug Targets, 23(17), 1578–1592. https://doi.org/10.2174/1389450123666221011102250
Chicago
Sugimoto, Michelle A, Luiza O Perucci, Luciana P Tavares, Mauro M Teixeira, and Lirlândia P Sousa. 2022. “Fibrinolysis in COVID-19: Impact on Clot Lysis and Modulation of Inflammation.” Current Drug Targets 23 (17): 1578–92. doi:10.2174/1389450123666221011102250.